We started Coadia because CNS disorders such as depression, schizophrenia, and Alzheimer's are complex and underserved. Drug development is slow, clinical evidence is fragmented, and payers demand data that no one is capturing. We saw an opportunity to fix that.
Coadia is a clinical AI platform built for the CNS space. We transform clinician-patient interactions into structured, regulatory-grade datasets. There is no extra data entry, no disconnected silos, and no compromise between research and care.
Every module, pipeline, and algorithm is designed for neurology, psychiatry, and cognitive health.
Every data point connects back to the original audio, timestamp, and clinical context, creating a complete audit trail.
We create a continuous data flow from trial design to market access and real-world use.
Our scientists, clinicians, and engineers bring deep expertise in CNS and regulatory science.
Coadia partners with leading pharmaceutical companies, CROs, and academic centers. Our pilots have improved patient recruitment, accelerated evidence generation, and supported payer acceptance.
Join leading pharmaceutical companies already using our platform to accelerate their CNS programs.